Clinical Trial Update: Mesenchymal Stem Cells for Radiation-induced Xerostomia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating mesenchymal stem cells for radiation-induced xerostomia (dry mouth) with long-term adverse effects; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Toxicity
• Xerostomia Due to Radiotherapy

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Radiation Toxicity, Xerostomia Due to Radiotherapy | Phase 1, Phase 2 | Status: UNKNOWN